EHC vs. SEM, GMED, LHCG, RXDX, IONS, LNTH, SHC, ENSG, ROIV, and MEDP
Should you be buying Encompass Health stock or one of its competitors? The main competitors of Encompass Health include Select Medical (SEM), Globus Medical (GMED), LHC Group (LHCG), Prometheus Biosciences (RXDX), Ionis Pharmaceuticals (IONS), Lantheus (LNTH), Sotera Health (SHC), The Ensign Group (ENSG), Roivant Sciences (ROIV), and Medpace (MEDP). These companies are all part of the "medical" sector.
Encompass Health vs.
Select Medical (NYSE:SEM) and Encompass Health (NYSE:EHC) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, institutional ownership, dividends, valuation, media sentiment, analyst recommendations, community ranking, earnings and risk.
Select Medical presently has a consensus price target of $33.75, indicating a potential upside of 36.97%. Encompass Health has a consensus price target of $69.00, indicating a potential upside of 31.75%. Given Select Medical's higher possible upside, equities analysts clearly believe Select Medical is more favorable than Encompass Health.
In the previous week, Encompass Health had 2 more articles in the media than Select Medical. MarketBeat recorded 5 mentions for Encompass Health and 3 mentions for Select Medical. Encompass Health's average media sentiment score of 0.90 beat Select Medical's score of 0.69 indicating that Encompass Health is being referred to more favorably in the news media.
Encompass Health received 152 more outperform votes than Select Medical when rated by MarketBeat users. Likewise, 72.27% of users gave Encompass Health an outperform vote while only 57.85% of users gave Select Medical an outperform vote.
78.8% of Select Medical shares are held by institutional investors. Comparatively, 96.1% of Encompass Health shares are held by institutional investors. 19.1% of Select Medical shares are held by insiders. Comparatively, 2.7% of Encompass Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Encompass Health has a net margin of 5.54% compared to Select Medical's net margin of 2.51%. Encompass Health's return on equity of 16.15% beat Select Medical's return on equity.
Encompass Health has lower revenue, but higher earnings than Select Medical. Encompass Health is trading at a lower price-to-earnings ratio than Select Medical, indicating that it is currently the more affordable of the two stocks.
Select Medical pays an annual dividend of $0.50 per share and has a dividend yield of 2.0%. Encompass Health pays an annual dividend of $0.60 per share and has a dividend yield of 1.1%. Select Medical pays out 40.7% of its earnings in the form of a dividend. Encompass Health pays out 22.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Select Medical has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. Comparatively, Encompass Health has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500.
Summary
Encompass Health beats Select Medical on 15 of the 21 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding EHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Encompass Health Competitors List
